UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Successful drug development – getting it right from the start
When it comes to successful drug development, today’s pharma and biotech co...
by Lee Han-soo
|
2019-12-20 16:30
라인
Pfizer wins Champix patent suit against 20 local generics makers
Pfizer won a patent lawsuit against local drugmakers over its antismoking d...
by Jeong Sae-im
|
2019-12-20 16:28
라인
Chemas to research anticancer treatment in Germany
Chemas, a local pharmaceutical company, said that it has completed its prep...
by Lee Han-soo
|
2019-12-20 15:18
라인
Bridge Biotherapeutics seeks IND status for lung cancer treatment
Bridge Biotherapeutics said it has filed an investigational new drug (IND) ...
by Lee Han-soo
|
2019-12-20 14:41
라인
Boehringer Ingelheim stops developing Pharmaxis’ NASH treatment candidate
Boehringer Ingelheim said that it has decided to discontinue its developmen...
by Lee Han-soo
|
2019-12-19 17:42
라인
AstraZeneca, Korean partners launch joint project to accelerate bio-health innovation
AstraZeneca said that it has signed a memorandum of understanding with four...
by Lee Han-soo
|
2019-12-19 17:40
라인
AstraZeneca, SK Holdings celebrates manufacturing partnership
AstraZeneca and SK Holdings said they have reached an important milestone i...
by Lee Han-soo
|
2019-12-19 16:39
라인
Daewoong wins sales approval for Nabota in UAE, Indonesia
Daewoong Pharmaceutical said that it has received sales approval for its bo...
by Lee Han-soo
|
2019-12-19 12:09
라인
Crystal Genomics acquires Hwail as subsidiary
Crystal Genomics said that it has acquired Hwail Pharmaceutical as its subs...
by Lee Han-soo
|
2019-12-18 17:48
라인
4 new botulinum toxins to undergo trials in crowded market
Small and mid-size domestic companies are rushing to develop botulinum toxi...
by Jeong Sae-im
|
2019-12-18 15:29
라인
‘Roche's Xofluza to revolutionize influenza antivirals’
Roche Korea’s Xofluza is a new influenza treatment, a first-in-class, singl...
by Lee Han-soo
|
2019-12-17 16:30
라인
Novartis reaffirms efficacy of Tasigna in treating chronic myelogenous leukemia
Novartis Korea said that it has affirmed the efficacy of Tasigna, a chronic...
by Lee Han-soo
|
2019-12-17 14:48
라인
CDK4/6+fulvestrant combo may get benefit in 1st half of 2020
The combination therapy of cyclin-dependent kinase 4/6 (CDK 4/6) inhibitor ...
by Kim Yun-mi
|
2019-12-17 11:59
라인
CJ Healthcare unites with Standigm to develop AI-based anticancer drugs
CJ Healthcare said that it plans to develop new anticancer drugs jointly wi...
by Lee Han-soo
|
2019-12-17 11:58
라인
Dong-A, Meiji Seika to conduct P1 trial for Stelara biosimilar
Dong-A Socio Holdings and Meiji Seika Pharmaceutical said they have started...
by Lee Han-soo
|
2019-12-16 17:01
라인
Huons Lab, Pangen to codevelop human genetic recombinant hyaluronidase
Huons Lab, a subsidiary of Huons, said that it would cooperate in developin...
by Lee Han-soo
|
2019-12-16 15:23
라인
KDA tells patients not to stop taking metformin arbitrarily
The Korean Diabetes Association (KDA) has warned diabetic patients against ...
by Lee Han-soo
|
2019-12-16 10:56
라인
GC, Add Pharma to co-develop synthetic drugs
GC said that it has agreed with Add Pharmaceutical to cooperate on developi...
by Lee Han-soo
|
2019-12-13 16:25
라인
Daewoong releases trial results for autoimmune disease treatment candidate
Daewoong Pharmaceutical said that it has presented the research results of ...
by Lee Han-soo
|
2019-12-13 15:12
라인
GC Labcell releases trial results of NK-cell combination treatment
GC Labcell has presented the preclinical trial data for new blood cancer tr...
by Lee Han-soo
|
2019-12-12 18:00
-
이전
21
22
23
24
25
26
27
28
29
30
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top